Apontis Pharma AG (APPH) — Cash Flow Quality Index
Apontis Pharma AG (APPH) has a Cash Flow Quality Index of -3.22x as of June 2025. Operating cash flow of €-1.94 Million is below net income of €603.75K, suggesting accrual-heavy earnings not yet converted to cash. Also explore Apontis Pharma AG assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apontis Pharma AG Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for Apontis Pharma AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Apontis Pharma AG to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Apontis Pharma AG (2022–2024)
Year-by-year earnings quality comparison for Apontis Pharma AG. For live market cap and the full company financial profile, see Apontis Pharma AG market cap and net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -3.85x | €-2.90 Million | €753.57K | ▼ -193.9% |
| 2022 | 4.10x | €11.02 Million | €2.69 Million | — |